drugset / Trial / NCT03523754

Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor

NCT03523754

Phase 1/2 Unknown 50 enrolled Dina Yahia Mansour
RandomizedParallel-groupOpen-labelSupportive care

Summary

Evaluation of safety \& efficacy of nitric oxide donors such as intravaginal isosorbide mononitrate in addition to misoprostol Versus misoprostol only for the whole process of induction of labor.

Timeline

Start
2018-01-01
Primary completion
2018-10-01
Completion
2018-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 40 mg
Background Misoprostol Other / unclassified 25 ug

Indications

No indication recorded.